Metastases resection after FOLFIRI-aflibercept (FA) in oxaliplatin-refractory colorectal cancer patients (ORF-CRC).

Authors

null

Andres J. Muñoz Martín

Hospital General Universitario Gregorio Marañón, Madrid, Spain

Andres J. Muñoz Martín , Silvia Garcia Adrian , Carles Pericay , Ana Ruíz , Patricia Ibeas , Rosana Grandez , Elena Diaz Pena Jr., Ana Maria Lopez , Juez MARTEL Ignacio , Irene Gonzalez Cebrian , Sara Encinas García , Julia Alcaide , Ana Fernandez Fernandez Montes , Carmen Soriano , Teresa Mercade Macarulla , Beatriz García-Paredes , Gema Pulido , Jose M. Mazo , Nuria Rodriguez Salas , Pilar Garcia Alfonso

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Citation

J Clin Oncol 36, 2018 (suppl 4S; abstr 862)

DOI

10.1200/JCO.2018.36.4_suppl.862

Abstract #

862

Poster Bd #

P14

Abstract Disclosures